(MedPage Today) -- ATLANTA -- Having shingles boosted the risk of major adverse cardiovascular events (MACE) such as vascular dementia, heart attack, stroke, and death by roughly a quarter --...

(MedPage Today) -- ATLANTA -- Mortality rates from Clostridioides difficile-related infections have fallen steadily since 2016, but the condition continues to take an uneven lethal toll based on sex, demographics,...

(MedPage Today) -- BERLIN -- Belzutifan (Welireg) induced durable responses in advanced pheochromocytoma or paraganglioma (PPGL) in a single-arm phase II trial, evidence that supported FDA's recent approval in these...

(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz Source link : https://www.medpagetoday.com/quizzes/news-quiz/118005 Author : Publish date : 2025-10-18 21:00:00 Copyright for syndicated...

(MedPage Today) -- BERLIN -- Almost half of patients with advanced ALK-positive non-small cell lung cancer (NSCLC) have lived 7 years or longer following initial treatment with the ALK inhibitor...

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president...

(MedPage Today) -- BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall survival (OS) in high-risk early breast cancer,...

Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care. Medscape Medical News Source link : https://www.medscape.com/viewarticle/durvalumab-plus-flot-ups-survival-early-upper-gi-cancer-2025a1000sar?src=rss Author : Publish date : 2025-10-18 16:41:00 Copyright...

(MedPage Today) -- BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased the number of cancers detected compared with SoC...

(MedPage Today) -- As I'm about to get out of my car and head into the hospital for my shift, I notice a shiny black Porsche wheel in. It is...

Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, high-risk early breast cancer, in the extended follow-up of a landmark trial. Medscape Medical News Source...

(MedPage Today) -- Here's a simple way to switch up your walking routine, according to experts: try going backward. Taking a brisk walk is an exercise rich in simplicity, and...

Charlotte Monjaria's weekend away with friends led to the discovery of a cancerous tumour. Source link : https://www.bbc.com/news/videos/c1e37n8y678o?at_medium=RSS&at_campaign=rss Author : Publish date : 2025-10-17 22:07:00 Copyright for syndicated content belongs...

A blood test for more than 50 types of cancer could help speed up diagnosis according to a new study.Results of a trial in north America show that the test...

Charlotte Morjario had no idea how her life was about to change when she went on a girls' holiday with her two best friends.The mother-of-one was having a "fantastic" time...

(MedPage Today) -- For children born with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), an investigational gene therapy showed sustained clinical efficacy and safety at a median follow-up...

(MedPage Today) -- The continuing federal government shutdown and cuts to the CDC mean that the U.S. may not be prepared for the next natural disaster, experts said Friday. "Every...

(MedPage Today) -- Bobby Mukkamala, MD, president of the American Medical Association (AMA), said he's looking forward to "growing our relationship" with the Trump administration at a recent event. But...

(MedPage Today) -- BERLIN -- Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly improved disease-free survival (DFS) in patients with BCG-naive, high-risk non-muscle-invasive bladder... Source link...

(MedPage Today) -- BERLIN -- In a global phase III trial, the addition of durvalumab (Imfinzi) to standard chemotherapy given before and after surgery led to a statistically significant and...